microRNA information: hsa-miR-511-5p
Section | ID | link |
---|---|---|
Mature name: | hsa-miR-511-5p | miRbase |
Accession: | MIMAT0002808 | miRbase |
Precursor name: | hsa-mir-511 | miRbase |
Precursor accession: | MI0003127 | miRbase |
Symbol: | NA | HGNC |
RefSeq ID: | NA | GenBank |
Sequence: | GUGUCUUUUGCUCUGCAGUCA |
Reported expression in cancers: hsa-miR-511-5p
miRNA | cancer | regulation | reporting | PUBMED | method |
---|---|---|---|---|---|
hsa-miR-511-5p | B cell lymphoma | deregulation | "Importantly decreased expression of miR-138-5p and ......" | 24914240 | |
hsa-miR-511-5p | liver cancer | downregulation | "In this study we found that miR-511 expression was ......" | 25608840 | |
hsa-miR-511-5p | sarcoma | downregulation | "Similar analysis in mouse metastatic sarcomas reve ......" | 26044957 |
Reported cancer pathway affected by hsa-miR-511-5p
miRNA | cancer | pathway | reporting | PUBMED | functional study |
---|---|---|---|---|---|
hsa-miR-511-5p | liver cancer | mTOR signaling pathway | "MiR 511 inhibits growth and metastasis of human he ......" | 25608840 | |
hsa-miR-511-5p | lung cancer | Apoptosis pathway; cell cycle pathway | "miR 511 induces the apoptosis of radioresistant lu ......" | 24402374 | Wound Healing Assay; Western blot |
Reported cancer prognosis affected by hsa-miR-511-5p
miRNA | cancer | prognosis | reporting | PUBMED | functional study |
---|---|---|---|---|---|
hsa-miR-511-5p | liver cancer | metastasis | "MiR 511 inhibits growth and metastasis of human he ......" | 25608840 | |
hsa-miR-511-5p | lung cancer | drug resistance | "miR 511 induces the apoptosis of radioresistant lu ......" | 24402374 | Wound Healing Assay; Western blot |
Reported gene related to hsa-miR-511-5p
miRNA | cancer | gene | reporting | PUBMED |
---|---|---|---|---|
hsa-miR-511-5p | lung cancer | TRIB2 | "miR 511 and miR 1297 inhibit human lung adenocarci ......" | 23071539 |
hsa-miR-511-5p | lung cancer | TRIB2 | "After downregulation of TRIB2 by miR-511 treatment ......" | 24402374 |
hsa-miR-511-5p | lung cancer | BAX | "miR 511 induces the apoptosis of radioresistant lu ......" | 24402374 |
hsa-miR-511-5p | liver cancer | MTOR | "Investigations of possible mechanisms underlying t ......" | 25608840 |
hsa-miR-511-5p | liver cancer | PIK3R3 | "MiR 511 inhibits growth and metastasis of human he ......" | 25608840 |
Expression profile in cancer corhorts:
Putative target regulations
miRNA | Gene | Cancer | Interaction | Correlation beta |
---|---|---|---|---|
hsa-miR-511-5p | FGF12 | 9 cancers: BLCA; HNSC; LIHC; LUAD; LUSC; PRAD; THCA; STAD; UCEC | MirTarget | TCGA BLCA -0.143; TCGA HNSC -0.232; TCGA LIHC -0.187; TCGA LUAD -0.342; TCGA LUSC -0.203; TCGA PRAD -0.303; TCGA THCA -0.478; TCGA STAD -0.256; TCGA UCEC -0.275 |
hsa-miR-511-5p | REEP1 | 9 cancers: BLCA; BRCA; CESC; COAD; PRAD; SARC; THCA; STAD; UCEC | MirTarget | TCGA BLCA -0.201; TCGA BRCA -0.3; TCGA CESC -0.3; TCGA COAD -0.547; TCGA PRAD -0.108; TCGA SARC -0.649; TCGA THCA -0.138; TCGA STAD -0.629; TCGA UCEC -0.197 |
hsa-miR-511-5p | BBS2 | 9 cancers: BLCA; COAD; KIRC; KIRP; OV; PRAD; SARC; STAD; UCEC | MirTarget | TCGA BLCA -0.112; TCGA COAD -0.076; TCGA KIRC -0.096; TCGA KIRP -0.068; TCGA OV -0.054; TCGA PRAD -0.068; TCGA SARC -0.054; TCGA STAD -0.115; TCGA UCEC -0.1 |
hsa-miR-511-5p | PCMTD1 | 11 cancers: BLCA; CESC; COAD; ESCA; LUAD; OV; PRAD; SARC; THCA; STAD; UCEC | MirTarget | TCGA BLCA -0.181; TCGA CESC -0.093; TCGA COAD -0.157; TCGA ESCA -0.127; TCGA LUAD -0.084; TCGA OV -0.067; TCGA PRAD -0.056; TCGA SARC -0.166; TCGA THCA -0.125; TCGA STAD -0.23; TCGA UCEC -0.117 |
hsa-miR-511-5p | PAN3 | 9 cancers: BLCA; CESC; COAD; ESCA; KIRP; LUAD; OV; STAD; UCEC | MirTarget | TCGA BLCA -0.113; TCGA CESC -0.06; TCGA COAD -0.124; TCGA ESCA -0.093; TCGA KIRP -0.119; TCGA LUAD -0.073; TCGA OV -0.083; TCGA STAD -0.119; TCGA UCEC -0.1 |
hsa-miR-511-5p | AMN1 | 14 cancers: BLCA; BRCA; CESC; HNSC; LIHC; LUAD; LUSC; OV; PAAD; PRAD; SARC; THCA; STAD; UCEC | MirTarget | TCGA BLCA -0.109; TCGA BRCA -0.075; TCGA CESC -0.111; TCGA HNSC -0.18; TCGA LIHC -0.121; TCGA LUAD -0.068; TCGA LUSC -0.108; TCGA OV -0.093; TCGA PAAD -0.132; TCGA PRAD -0.082; TCGA SARC -0.144; TCGA THCA -0.091; TCGA STAD -0.121; TCGA UCEC -0.124 |
hsa-miR-511-5p | POGZ | 14 cancers: BLCA; BRCA; CESC; ESCA; HNSC; KIRP; LIHC; LUAD; LUSC; OV; SARC; THCA; STAD; UCEC | MirTarget | TCGA BLCA -0.144; TCGA BRCA -0.073; TCGA CESC -0.119; TCGA ESCA -0.076; TCGA HNSC -0.081; TCGA KIRP -0.134; TCGA LIHC -0.229; TCGA LUAD -0.121; TCGA LUSC -0.115; TCGA OV -0.105; TCGA SARC -0.161; TCGA THCA -0.064; TCGA STAD -0.088; TCGA UCEC -0.137 |
hsa-miR-511-5p | MXI1 | 10 cancers: BLCA; HNSC; KIRC; LUAD; LUSC; PRAD; SARC; THCA; STAD; UCEC | MirTarget | TCGA BLCA -0.124; TCGA HNSC -0.112; TCGA KIRC -0.103; TCGA LUAD -0.093; TCGA LUSC -0.098; TCGA PRAD -0.072; TCGA SARC -0.187; TCGA THCA -0.155; TCGA STAD -0.215; TCGA UCEC -0.081 |
hsa-miR-511-5p | VANGL2 | 9 cancers: BLCA; COAD; HNSC; LUAD; LUSC; OV; SARC; STAD; UCEC | MirTarget | TCGA BLCA -0.149; TCGA COAD -0.279; TCGA HNSC -0.228; TCGA LUAD -0.182; TCGA LUSC -0.454; TCGA OV -0.132; TCGA SARC -0.363; TCGA STAD -0.304; TCGA UCEC -0.218 |
hsa-miR-511-5p | PPARGC1A | 11 cancers: BLCA; ESCA; HNSC; KIRC; KIRP; LUAD; PRAD; SARC; THCA; STAD; UCEC | MirTarget | TCGA BLCA -0.285; TCGA ESCA -0.526; TCGA HNSC -0.202; TCGA KIRC -0.276; TCGA KIRP -0.153; TCGA LUAD -0.352; TCGA PRAD -0.27; TCGA SARC -0.551; TCGA THCA -0.648; TCGA STAD -0.575; TCGA UCEC -0.316 |
hsa-miR-511-5p | SLC22A17 | 10 cancers: BLCA; BRCA; CESC; HNSC; PAAD; PRAD; SARC; THCA; STAD; UCEC | MirTarget | TCGA BLCA -0.303; TCGA BRCA -0.124; TCGA CESC -0.154; TCGA HNSC -0.265; TCGA PAAD -0.231; TCGA PRAD -0.121; TCGA SARC -0.357; TCGA THCA -0.122; TCGA STAD -0.277; TCGA UCEC -0.21 |
hsa-miR-511-5p | ZNF250 | 13 cancers: BLCA; CESC; COAD; HNSC; KIRP; LIHC; LUAD; LUSC; OV; SARC; THCA; STAD; UCEC | MirTarget | TCGA BLCA -0.136; TCGA CESC -0.058; TCGA COAD -0.162; TCGA HNSC -0.061; TCGA KIRP -0.163; TCGA LIHC -0.125; TCGA LUAD -0.052; TCGA LUSC -0.052; TCGA OV -0.091; TCGA SARC -0.14; TCGA THCA -0.087; TCGA STAD -0.117; TCGA UCEC -0.088 |
hsa-miR-511-5p | PLEKHA1 | 10 cancers: BLCA; COAD; ESCA; HNSC; KIRC; KIRP; LUAD; SARC; THCA; STAD | MirTarget | TCGA BLCA -0.074; TCGA COAD -0.084; TCGA ESCA -0.073; TCGA HNSC -0.067; TCGA KIRC -0.092; TCGA KIRP -0.092; TCGA LUAD -0.116; TCGA SARC -0.082; TCGA THCA -0.095; TCGA STAD -0.11 |
hsa-miR-511-5p | SPAG17 | 9 cancers: BLCA; BRCA; CESC; HNSC; KIRC; KIRP; SARC; STAD; UCEC | MirTarget | TCGA BLCA -0.296; TCGA BRCA -0.137; TCGA CESC -0.382; TCGA HNSC -0.234; TCGA KIRC -0.218; TCGA KIRP -0.355; TCGA SARC -0.312; TCGA STAD -0.183; TCGA UCEC -0.486 |
hsa-miR-511-5p | NLK | 11 cancers: BLCA; BRCA; CESC; COAD; ESCA; KIRP; LIHC; LUSC; PAAD; THCA; UCEC | MirTarget | TCGA BLCA -0.057; TCGA BRCA -0.092; TCGA CESC -0.058; TCGA COAD -0.117; TCGA ESCA -0.082; TCGA KIRP -0.076; TCGA LIHC -0.105; TCGA LUSC -0.079; TCGA PAAD -0.116; TCGA THCA -0.096; TCGA UCEC -0.051 |
hsa-miR-511-5p | MYEF2 | 11 cancers: BLCA; BRCA; CESC; KIRC; KIRP; LUAD; OV; PAAD; SARC; STAD; UCEC | MirTarget | TCGA BLCA -0.284; TCGA BRCA -0.138; TCGA CESC -0.416; TCGA KIRC -0.158; TCGA KIRP -0.197; TCGA LUAD -0.089; TCGA OV -0.089; TCGA PAAD -0.168; TCGA SARC -0.514; TCGA STAD -0.514; TCGA UCEC -0.105 |
hsa-miR-511-5p | CNTD1 | 12 cancers: BLCA; BRCA; CESC; COAD; ESCA; HNSC; KIRC; KIRP; LIHC; LUAD; LUSC; PAAD | MirTarget | TCGA BLCA -0.102; TCGA BRCA -0.167; TCGA CESC -0.103; TCGA COAD -0.17; TCGA ESCA -0.147; TCGA HNSC -0.182; TCGA KIRC -0.131; TCGA KIRP -0.171; TCGA LIHC -0.141; TCGA LUAD -0.095; TCGA LUSC -0.119; TCGA PAAD -0.21 |
hsa-miR-511-5p | INO80D | 9 cancers: BLCA; CESC; ESCA; KIRP; LIHC; LUAD; SARC; STAD; UCEC | MirTarget | TCGA BLCA -0.105; TCGA CESC -0.069; TCGA ESCA -0.109; TCGA KIRP -0.076; TCGA LIHC -0.064; TCGA LUAD -0.065; TCGA SARC -0.091; TCGA STAD -0.07; TCGA UCEC -0.056 |
hsa-miR-511-5p | ZNF652 | 11 cancers: BLCA; BRCA; CESC; ESCA; HNSC; KIRP; LIHC; LUAD; LUSC; THCA; STAD | MirTarget | TCGA BLCA -0.177; TCGA BRCA -0.093; TCGA CESC -0.113; TCGA ESCA -0.135; TCGA HNSC -0.08; TCGA KIRP -0.079; TCGA LIHC -0.073; TCGA LUAD -0.088; TCGA LUSC -0.068; TCGA THCA -0.117; TCGA STAD -0.07 |
hsa-miR-511-5p | CBR4 | 11 cancers: BLCA; BRCA; COAD; ESCA; KIRC; KIRP; LUSC; PAAD; SARC; THCA; STAD | MirTarget | TCGA BLCA -0.2; TCGA BRCA -0.054; TCGA COAD -0.082; TCGA ESCA -0.089; TCGA KIRC -0.114; TCGA KIRP -0.069; TCGA LUSC -0.054; TCGA PAAD -0.088; TCGA SARC -0.084; TCGA THCA -0.135; TCGA STAD -0.172 |
hsa-miR-511-5p | TTC23L | 11 cancers: BLCA; BRCA; CESC; KIRC; KIRP; LUAD; LUSC; OV; PAAD; THCA; UCEC | MirTarget | TCGA BLCA -0.357; TCGA BRCA -0.237; TCGA CESC -0.284; TCGA KIRC -0.167; TCGA KIRP -0.331; TCGA LUAD -0.158; TCGA LUSC -0.173; TCGA OV -0.194; TCGA PAAD -0.268; TCGA THCA -0.244; TCGA UCEC -0.271 |
hsa-miR-511-5p | ZNF780B | 14 cancers: BLCA; CESC; ESCA; HNSC; KIRC; KIRP; LIHC; LUSC; OV; PAAD; PRAD; SARC; THCA; STAD | MirTarget | TCGA BLCA -0.195; TCGA CESC -0.13; TCGA ESCA -0.164; TCGA HNSC -0.064; TCGA KIRC -0.091; TCGA KIRP -0.168; TCGA LIHC -0.109; TCGA LUSC -0.063; TCGA OV -0.081; TCGA PAAD -0.088; TCGA PRAD -0.06; TCGA SARC -0.124; TCGA THCA -0.13; TCGA STAD -0.182 |
hsa-miR-511-5p | ADAMTS17 | 9 cancers: BLCA; ESCA; HNSC; KIRC; LUSC; OV; PRAD; STAD; UCEC | MirTarget | TCGA BLCA -0.189; TCGA ESCA -0.252; TCGA HNSC -0.19; TCGA KIRC -0.181; TCGA LUSC -0.333; TCGA OV -0.16; TCGA PRAD -0.077; TCGA STAD -0.206; TCGA UCEC -0.35 |
hsa-miR-511-5p | LRP2BP | 10 cancers: BLCA; BRCA; CESC; HNSC; KIRC; KIRP; PAAD; SARC; THCA; STAD | MirTarget | TCGA BLCA -0.157; TCGA BRCA -0.058; TCGA CESC -0.118; TCGA HNSC -0.111; TCGA KIRC -0.113; TCGA KIRP -0.224; TCGA PAAD -0.2; TCGA SARC -0.224; TCGA THCA -0.156; TCGA STAD -0.297 |
hsa-miR-511-5p | ZNF480 | 9 cancers: BLCA; KIRC; KIRP; LIHC; LUAD; LUSC; OV; THCA; STAD | MirTarget | TCGA BLCA -0.144; TCGA KIRC -0.073; TCGA KIRP -0.113; TCGA LIHC -0.14; TCGA LUAD -0.113; TCGA LUSC -0.118; TCGA OV -0.083; TCGA THCA -0.125; TCGA STAD -0.163 |
hsa-miR-511-5p | STOX2 | 9 cancers: BLCA; HNSC; KIRP; LUSC; PRAD; SARC; THCA; STAD; UCEC | MirTarget | TCGA BLCA -0.128; TCGA HNSC -0.148; TCGA KIRP -0.106; TCGA LUSC -0.198; TCGA PRAD -0.156; TCGA SARC -0.478; TCGA THCA -0.13; TCGA STAD -0.243; TCGA UCEC -0.164 |
hsa-miR-511-5p | SPATA6 | 9 cancers: BLCA; CESC; ESCA; HNSC; PRAD; SARC; THCA; STAD; UCEC | MirTarget | TCGA BLCA -0.285; TCGA CESC -0.519; TCGA ESCA -0.347; TCGA HNSC -0.245; TCGA PRAD -0.133; TCGA SARC -0.157; TCGA THCA -0.129; TCGA STAD -0.217; TCGA UCEC -0.154 |
hsa-miR-511-5p | GIGYF1 | 13 cancers: BLCA; BRCA; CESC; HNSC; KIRC; KIRP; LIHC; LUSC; OV; PAAD; SARC; STAD; UCEC | MirTarget | TCGA BLCA -0.096; TCGA BRCA -0.104; TCGA CESC -0.06; TCGA HNSC -0.079; TCGA KIRC -0.106; TCGA KIRP -0.168; TCGA LIHC -0.152; TCGA LUSC -0.162; TCGA OV -0.073; TCGA PAAD -0.128; TCGA SARC -0.064; TCGA STAD -0.059; TCGA UCEC -0.097 |
hsa-miR-511-5p | SOX12 | 11 cancers: BRCA; CESC; HNSC; KIRP; LIHC; LUAD; LUSC; OV; PAAD; SARC; THCA | MirTarget | TCGA BRCA -0.282; TCGA CESC -0.086; TCGA HNSC -0.147; TCGA KIRP -0.112; TCGA LIHC -0.232; TCGA LUAD -0.15; TCGA LUSC -0.317; TCGA OV -0.108; TCGA PAAD -0.216; TCGA SARC -0.154; TCGA THCA -0.163 |
hsa-miR-511-5p | MAP7 | 9 cancers: BRCA; COAD; ESCA; KIRC; KIRP; LUAD; LUSC; PAAD; THCA | MirTarget | TCGA BRCA -0.135; TCGA COAD -0.095; TCGA ESCA -0.153; TCGA KIRC -0.206; TCGA KIRP -0.057; TCGA LUAD -0.159; TCGA LUSC -0.14; TCGA PAAD -0.174; TCGA THCA -0.054 |
hsa-miR-511-5p | HSD11B2 | 11 cancers: BRCA; CESC; COAD; ESCA; HNSC; LIHC; LUAD; LUSC; OV; PRAD; THCA | MirTarget | TCGA BRCA -0.229; TCGA CESC -0.173; TCGA COAD -0.244; TCGA ESCA -0.193; TCGA HNSC -0.158; TCGA LIHC -0.281; TCGA LUAD -0.169; TCGA LUSC -0.169; TCGA OV -0.105; TCGA PRAD -0.133; TCGA THCA -0.492 |
hsa-miR-511-5p | ZBTB41 | 10 cancers: BRCA; CESC; COAD; LIHC; LUAD; LUSC; OV; PRAD; SARC; STAD | MirTarget | TCGA BRCA -0.098; TCGA CESC -0.068; TCGA COAD -0.082; TCGA LIHC -0.154; TCGA LUAD -0.143; TCGA LUSC -0.12; TCGA OV -0.079; TCGA PRAD -0.061; TCGA SARC -0.098; TCGA STAD -0.063 |
hsa-miR-511-5p | GORAB | 9 cancers: CESC; COAD; HNSC; LIHC; LUAD; LUSC; OV; STAD; UCEC | MirTarget | TCGA CESC -0.098; TCGA COAD -0.066; TCGA HNSC -0.096; TCGA LIHC -0.088; TCGA LUAD -0.112; TCGA LUSC -0.168; TCGA OV -0.064; TCGA STAD -0.077; TCGA UCEC -0.094 |
hsa-miR-511-5p | TTC33 | 11 cancers: CESC; COAD; HNSC; KIRP; LIHC; LUAD; PRAD; SARC; THCA; STAD; UCEC | MirTarget | TCGA CESC -0.075; TCGA COAD -0.071; TCGA HNSC -0.058; TCGA KIRP -0.062; TCGA LIHC -0.072; TCGA LUAD -0.082; TCGA PRAD -0.101; TCGA SARC -0.142; TCGA THCA -0.056; TCGA STAD -0.145; TCGA UCEC -0.065 |
hsa-miR-511-5p | IRF2BP2 | 9 cancers: COAD; ESCA; LIHC; LUAD; LUSC; PAAD; THCA; STAD; UCEC | MirTarget | TCGA COAD -0.103; TCGA ESCA -0.084; TCGA LIHC -0.127; TCGA LUAD -0.103; TCGA LUSC -0.08; TCGA PAAD -0.069; TCGA THCA -0.085; TCGA STAD -0.081; TCGA UCEC -0.09 |
Enriched cancer pathways of putative targets